Does Percutaneous Transluminal Angioplasty Improve Quality of Life?

Journal of Vascular and Interventional Radiology

Volumn 19, Issue 2, 2008, Pages 169-176

  Keeling, Aoife N ^a   Naughton, Peter A ^a   O'Connell, AnnaMarie ^a   Lee, Michael J ^a  

^a BEAUMONT HOSPITAL   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID;

ADULT; AGED; ARTICLE; FEMALE; HUMAN; INTERMITTENT CLAUDICATION; LIMB ISCHEMIA; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; SCORING SYSTEM; SHORT FORM 36; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; ANGIOPLASTY, BALLOON; FEMALE; HUMANS; INTERMITTENT CLAUDICATION; ISCHEMIA; LEG; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; QUALITY OF LIFE; QUESTIONNAIRES;

EID: 38349114505     PISSN: 10510443     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jvir.2007.09.003     Document Type: Article

References (47)

1. Fowkes F.G.R., Housley E., Cawood E.H.H., MacIntyree C.C.A., Ruckley C.V., and Prescott R.J. Edinburgh Artery Study: prevalence of asymptomatic and symptomatic peripheral arterial disease in the general population. Int J Epidemiol 20 (1991) 384-392
2. Bainton D., Sweetnam P., Baker I., and Elwood P. Peripheral vascular disease: consequence for survival and association with risk factors in the Speedwell prospective heart disease study. Br Heart J 72 (1994) 128-132
3. Smith W.C.S., Woodward M., and Tunstall-Pedoe H. Intermittent claudication in Scotland. In: Fowkes F.G.R. (Ed). Epidemiology of peripheral vascular disease (1991), Springer-Verlag, London 117-124
4. Second European Consensus Document on Chronic Critical Limb Ischaemia. Circulation 84 suppl 3 (1991) 1-26
5. Weitz J.I., Byrne J., Clagett G.P., et al. Diagnosis and treatment of chronic arterial insufficiency of the lower extremities: a critical review. Circulation 94 (1996) 3026-3049
6. Selvin E., and Erlinger T.P. Prevalence and risk factors for peripheral arterial disease in the United States: results from the national health and nutrition examination survey, 1999-2000. Circulation 110 (2004) 738-743
7. Whyman M.R., Fowkes F.G.R., Kerracher E.M.G., et al. Randomised controlled trial of percutaneous transluminal angioplasty for intermittent claudication. Eur J Vasc Endovasc Surg 12 (1996) 167-172
8. Creasy T.S., McMillan P.J., Fletcher E.W.L., Collin J., and Morris P.J. Is percutaneous transluminal angioplasty better than exercise for claudication?. Preliminary results from a prospective randomised trial. Eur J Vasc Surg 4 (1990) 135-140
9. Whyman M.R., Fowkes F.G.R., Kerracher E.M.G., et al. Is intermittent claudication improved by percutaneous transluminal angioplasty?. A randomized controlled trial. J Vasc Surg 26 (1997) 551-557
10. Perkins J.M.T., Collin J., Creasy T.S., Fletcher E.W.L., and Morris P.J. Exercise training versus angioplasty for stable claudication. Long and medium term results of a prospective, randomised trial. Eur J Vasc Endovasc Surg 11 (1996) 409-413
11. Chong P.F.S., Golledge J., Greenhalgh R.M., and Davies A.H. Exercise therapy or angioplasty?. A summation analysis. Eur J Vasc Endovasc Surg 20 (2000) 4-12
12. Wolf G.L., Wilson S.E., Cross A.P., Deupree R.H., and Stason W.B. Surgery or balloon angioplasty for peripheral vascular disease: a randomized clinical trial. Principal investigators and their Associates of Veterans Administration Cooperative Study Number 199. J Vasc Interv Radiol 4 (1993) 639-648
13. Jackson M.J., and Wolfe J.H. Are infra-inguinal angioplasty and surgery comparable?. Acta Chir Belg 101 (2001) 6-10
14. Hunink M.G., Wong J.B., Donaldson M.C., Meyerovitz M.F., de Vries J., and Harrington D.P. Revascularization for femoropopliteal disease: a decision and cost- effectiveness analysis. JAMA 274 (1995) 165-171
15. Garratt A., Schmidt L., Mackintosh A., and Fitzpatrick R. Quality of life measurement: bibliographic study of patient assessed health outcome measures. Br Med J 324 (2002) 1417-1421
16. Hunink M.G.M., and Meyerovitz M.F. The use of angioplasty, bypass surgery, and amputation in the management of peripheral vascular disease. N Engl J Med 326 (1992) 414
17. Testa M.A., and Lenderking W.R. Interpreting pharmacoeconomic and quality of life clinical trial data for use in therapeutics. Pharmacoeconomics 2 (1992) 107-117
18. Currie I.C., Wilson Y.G., Baird R.N., and Lamont P.M. Treatment of intermittent claudication: the impact on quality of life. Eur J Vasc Endovasc Surg 10 (1995) 356-361
19. Chetter I.C., Spark J.I., Kent P.J., Berridge D.C., Scott D.J.A., and Kester R.C. Percutaneous transluminal angioplasty for intermittent claudication: Evidence on which to base the medicine. Eur J Vasc Endovasc Surg 16 (1998) 477-484
20. Pell J.P., and Lee A.J. Impact of angioplasty and arterial reconstructive surgery on the quality of life of claudicants. The Scottish Vascular Audit Group. Scott Med J 42 (1997) 47-48
21. Bosch J.L., van der Graaf Y., and Hunink M.G.M. Health-related quality of life after angioplasty and stent placement in patients with iliac artery occlusive disease. Circulation 99 (1999) 3155-3160
22. Fowkes F.G.R. Epidemiology of atherosclerotic arterial disease in the lower limbs. Eur J Vasc Surg 2 (1988) 283-291
23. Khaira H.S., Hanger R., and Shearman C.P. Quality of life in patients with intermittent claudication. Eur J Vasc Endovasc Surg 11 (1996) 65-69
24. Ware J.E., and Sherbourne C.D. The MOS 36-item short form health survey (SF-36) I. Conceptual framework and item selection. Med Care 30 (1992) 473-483
25. Blake C., Codd M.B., and O'Meara Y.M. The short form 36 (SF-36) health survey: normative data for the Irish population. Ir J Med Sci 169 (2000) 195-200
26. Ware J.E. SF-36 health survey manual and interpretation guide (1993), Nimrod Press, Boston MA
27. Kalman P.G., Johnston K.W., and Sniderman K.W. Indications and results of balloon angioplasty for arterial occlusive lesions. World J Surg 20 (1996) 630-634
28. Matsi P.J., Manninem H.I., Soder H.K., Mustonen P., and Kouri J. Percutaneous transluminal angioplasty in femoral artery occlusions: primary and long-term results in 107 claudicant patients using femoral and popliteal catheterization techniques. Clin Radiol 50 (1995) 237-244
29. Bradbury A.W., and Ruckley C.V. Angioplasty for lower limb ischaemia: time for randomised controlled trials. Lancet 347 (1996) 277-278
30. Patrick D.L., Bush J.W., and Chen M.M. Toward an operational definition of health. J Health Soc Behav 14 (1973) 6-23
31. Brook R.H., Ware Jr. J.E., Rogers W.H., et al. Does free care improve adults' health?. Results from a randomized controlled trial. N Engl J Med 309 (1983) 1426-1434
32. Testa M.A., and Simonson D.C. Assessment of quality of life outcomes. N Engl J Med 334 (1996) 835-840
33. Stewart A.L., Greenfield S., Hays R.D., et al. Functional status and well-being of patients with chronic conditions. JAMA 262 (1989) 907-913
34. Brazier J.E., Harper R., Jones N.M.B., et al. Validating the SF-36 health survey questionnaire: new outcome measure for primary care. Br Med J 305 (1992) 160-164
35. Garratt A.M., Ruta D.A., Abdalla M.I., Buckingham K., and Russell I.T. The SF-36 health survey questionnaire: an outcome measure suitable for routine use in the NHS?. BMJ 306 (1993) 1440-1444
36. McHorney C.A., Ware J.E., Lu J.F., and Sherbourne C.D. The MOS 36-item short-form health survey (SF-36). III: tests of data quality, scaling assumptions and reliability across diverse patient groups. Med Care 32 (1994) 40-66
37. Hemingway H., Stafford M., Stansfield S., Shipley M., and Marmot M. Is the SF-36 a valid measure of change in population health?. Results from the Whitehall II study. Br Med J 315 (1997) 1273-1279
38. Chetter I.C., Spark J.I., Dolan P., Scott D.J.A., and Kester R.C. Quality of life analysis in patients with lower limb ischaemia; suggestions for European standardisation. Eur J Vasc Endovasc Surg 13 (1997) 597-604
39. Kind P., and Carr-Hill R. The Nottingham health profile: a useful tool for epidemiologists?. Soc Sci Med 25 (1987) 905-910
40. Spronk S., Bosch J.L., Veen H.F., den Hoed P.T., and Hunink M.G.M. Intermittent claudication: functional capacity and quality of life after exercise training or percutaneous transluminal angioplasty-systematic review. Radiology 235 (2005) 833-842
41. Feringa H.H., Van Waning V.H., Bax J.J., et al. Cardioprotective medication is associated with improved survival in patients with peripheral arterial disease. J Am Coll Cardiol 47 (2006) 1182-1187
42. Goldhaber S.Z., Manson J.E., Stampfer M.J., et al. Low-dose aspirin and subsequent peripheral arterial surgery in the Physician's Health Study. Lancet 340 (1992) 143-145
43. Ridker P.M., Cushman M., Stampfer M.J., Tracy R.P., and Hennekens C.H. Plasma concentration of C-reactive protein and risk of developing peripheral vascular disease. Circulation 97 (1998) 425-428
44. Schillinger M., Exner M., Mlekusch W., et al. Vascular inflammation and percutaneous transluminal angioplasty of the femoropopliteal artery: association with restenosis. Radiology 225 (2002) 21-26
45. Fabry R., Dubost J.J., Pochon P., and Duchene-Marullaz P. Comparison of standard one- minute treadmill exercise and Strandness test (absolute walking distance) in relation to site of lesion, walking distance and diastolic blood flow velocity (Doppler curves). Angiology 41 (1990) 869-876
46. Abando A., Akopian G., and Katz S.G. Patient sex and success of peripheral percutaneous transluminal angioplasty. Arch Surg 140 (2005) 757-761
47. Kugler C.F.A., and Rudofsky G. Do age and comorbidity affect quality of life or PTA- induced quality of life improvements in patients with symptomatic PAD?. J Endovasc Ther 12 (2005) 387-393